Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |